188 related articles for article (PubMed ID: 24346034)
1. Immunology: glyco-engineering 'super-self'.
Macauley MS; Paulson JC
Nat Chem Biol; 2014 Jan; 10(1):7-8. PubMed ID: 24346034
[TBL] [Abstract][Full Text] [Related]
2. Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion.
Hudak JE; Canham SM; Bertozzi CR
Nat Chem Biol; 2014 Jan; 10(1):69-75. PubMed ID: 24292068
[TBL] [Abstract][Full Text] [Related]
3. The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression.
Zheng Y; Ma X; Su D; Zhang Y; Yu L; Jiang F; Zhou X; Feng Y; Ma F
J Immunol Res; 2020; 2020():6243819. PubMed ID: 32322597
[TBL] [Abstract][Full Text] [Related]
4. Viewing Siglecs through the lens of tumor immunology.
Fraschilla I; Pillai S
Immunol Rev; 2017 Mar; 276(1):178-191. PubMed ID: 28258691
[TBL] [Abstract][Full Text] [Related]
5. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
Linnartz-Gerlach B; Mathews M; Neumann H
Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
[TBL] [Abstract][Full Text] [Related]
6. Siglecs at the Host-Pathogen Interface.
Chang YC; Nizet V
Adv Exp Med Biol; 2020; 1204():197-214. PubMed ID: 32152948
[TBL] [Abstract][Full Text] [Related]
7. Deacetylated sialic acids modulates immune mediated cytotoxicity via the sialic acid-Siglec pathway.
Grabenstein S; Barnard KN; Anim M; Armoo A; Weichert WS; Bertozzi CR; Parrish CR; Willand-Charnley R
Glycobiology; 2021 Nov; 31(10):1279-1294. PubMed ID: 34192335
[TBL] [Abstract][Full Text] [Related]
8. Precision glycocalyx editing as a strategy for cancer immunotherapy.
Xiao H; Woods EC; Vukojicic P; Bertozzi CR
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10304-9. PubMed ID: 27551071
[TBL] [Abstract][Full Text] [Related]
9. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
[TBL] [Abstract][Full Text] [Related]
10. Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer.
Daly J; Carlsten M; O'Dwyer M
Front Immunol; 2019; 10():1047. PubMed ID: 31143186
[TBL] [Abstract][Full Text] [Related]
11. Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells.
Adeniji OS; Kuri-Cervantes L; Yu C; Xu Z; Ho M; Chew GM; Shikuma C; Tomescu C; George AF; Roan NR; Ndhlovu LC; Liu Q; Muthumani K; Weiner DB; Betts MR; Xiao H; Abdel-Mohsen M
PLoS Pathog; 2021 Nov; 17(11):e1010034. PubMed ID: 34762717
[TBL] [Abstract][Full Text] [Related]
12. Sialic Acid Mimetics to Target the Sialic Acid-Siglec Axis.
Büll C; Heise T; Adema GJ; Boltje TJ
Trends Biochem Sci; 2016 Jun; 41(6):519-531. PubMed ID: 27085506
[TBL] [Abstract][Full Text] [Related]
13. Sialic acids in cancer biology and immunity.
Pearce OM; Läubli H
Glycobiology; 2016 Feb; 26(2):111-28. PubMed ID: 26518624
[TBL] [Abstract][Full Text] [Related]
14. Reduced sialylation triggers homeostatic synapse and neuronal loss in middle-aged mice.
Klaus C; Hansen JN; Ginolhac A; Gérard D; Gnanapragassam VS; Horstkorte R; Rossdam C; Buettner FFR; Sauter T; Sinkkonen L; Neumann H; Linnartz-Gerlach B
Neurobiol Aging; 2020 Apr; 88():91-107. PubMed ID: 32087947
[TBL] [Abstract][Full Text] [Related]
15. Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
Saini P; Adeniji OS; Bordoloi D; Kinslow J; Martinson J; Parent DM; Hong KY; Koshy J; Kulkarni AJ; Zilberstein NF; Balk RA; Moy JN; Giron LB; Tracy RP; Keshavarzian A; Muthumani K; Landay A; Weiner DB; Abdel-Mohsen M
mBio; 2023 Feb; 14(1):e0339322. PubMed ID: 36728420
[TBL] [Abstract][Full Text] [Related]
16. The search for the missing 'missing-self' receptor on natural killer cells.
Yokoyama WM
Scand J Immunol; 2002 Mar; 55(3):233-7. PubMed ID: 11940229
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Biological Evaluation of Small, High-Affinity Siglec-7 Ligands: Toward Novel Inhibitors of Cancer Immune Evasion.
Prescher H; Frank M; Gütgemann S; Kuhfeldt E; Schweizer A; Nitschke L; Watzl C; Brossmer R
J Med Chem; 2017 Feb; 60(3):941-956. PubMed ID: 28103033
[TBL] [Abstract][Full Text] [Related]
18. A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
Kumar V; McNerney ME
Nat Rev Immunol; 2005 May; 5(5):363-74. PubMed ID: 15841099
[TBL] [Abstract][Full Text] [Related]
19. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
[TBL] [Abstract][Full Text] [Related]
20. The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease.
Müller J; Nitschke L
Nat Rev Rheumatol; 2014 Jul; 10(7):422-8. PubMed ID: 24763061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
